Adverse events in people taking macrolide antibiotics versus placebo for any indication

Adverse events in people taking macrolide antibiotics versus placebo for any indication

<p><strong>BACKGROUND:</strong> Macrolide antibiotics (macrolides) are among the most commonly prescribed antibiotics worldwide and are used for a wide range of infections. However, macrolides also expose people to the risk of adverse events. The current understanding of adverse ev...

Detaylı Bibliyografya
Asıl Yazarlar:	Hansen, M, Scott, A, McCullough, A, Thorning, S, Aronson, J, Beller, E, Glasziou, P, Hoffmann, T, Clark, J, Mar, D
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Cochrane Collaboration 2019

Benzer Materyaller

Adverse events in patients taking cephalosporins versus placebo for any indication (protocol)
Yazar:: McCullough, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Addressing antibiotic resistance - focusing on acute respiratory infections in primary care.
Yazar:: Del Mar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Placebo-Related Adverse Events in Rheumatoid Arthritis
Yazar:: Ratna Shree Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

Voltammetric study of the partitioning of macrolide antibiotics at the water/nitrobenzene interface. Relationship to the pharmacokinetic profiling of macrolides
Yazar:: Zoran Mandic
Baskı/Yayın Bilgisi: (2014-09-01)

Macrolide antibiotic therapy in patients with cystic fibrosis
Yazar:: MH Schöni
Baskı/Yayın Bilgisi: (2003-05-01)

Administration of macrolide antibiotics increases cardiovascular risk
Yazar:: Yang Wu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Degradation of macrolide antibiotic in water by heterogeneous photocatalysis
Yazar:: A. Ounnar, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

The evolution of substrate discrimination in macrolide antibiotic resistance enzymes
Yazar:: Andrew C. Pawlowski, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Addition of macrolide antibiotics for hospital treatment of community-acquired pneumonia
Yazar:: Wei, J, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

The scatter of research: cross sectional comparison of randomised trials and systematic reviews across specialties.
Yazar:: Hoffmann, T, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Antibiotic resistance: what are the opportunities for primary care in alleviating the crisis?
Yazar:: Malene Plejdrup Hansen, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
Yazar:: Helen C. Steel, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Inhibiting Effect of Macrolide Polyene Antibiotics on Reproduction of Viruses
Yazar:: A. A. Bagirova, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Context-specific action of macrolide antibiotics on the eukaryotic ribosome
Yazar:: Maxim S. Svetlov, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
Yazar:: O'Sullivan, JW, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Association of Macrolide Resistance Genotypes and Synergistic Antibiotic Combinations for Combating Macrolide-Resistant MRSA Recovered from Hospitalized Patients
Yazar:: Amr S. Bishr, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Mechanism of Action of Macrolide Antibiotic Filipin on Cell and Lipid Membranes
Yazar:: A. A. Samedova, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Scaffold Modifications in Erythromycin Macrolide Antibiotics. A Chemical Minireview
Yazar:: Kjell Undheim
Baskı/Yayın Bilgisi: (2020-08-01)

Research on the treatment of Pseudomonas aeruginosa pneumonia in children by macrolide antibiotics
Yazar:: Huang Xu-qiang, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli.
Yazar:: Ho Young Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2007-02-01)

Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics
Yazar:: Bertrand Beckert, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant pneumonia
Yazar:: Eun-Ae Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Genetic Variations and Antibiotic-Related Adverse Events
Yazar:: Nicola Principi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Phenotypic Resistance of (MRSA) Clinical Isolates to Some Macrolide Antibiotic Groups
Yazar:: Ali Yaseen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Molecular Imprinted Polymers for Macrolides, Aminoglycosides and Some Other Biosynthetic Antibiotics
Yazar:: M. I. Yakhkind, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

In Vitro Impact of Macrolide Antibiotics on the Viability of Selected Mammalian Cell Lines
Yazar:: Eva Tvrdá, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Mechanisms of Resistance to Macrolide Antibiotics among <i>Staphylococcus aureus</i>
Yazar:: Maria Miklasińska-Majdanik
Baskı/Yayın Bilgisi: (2021-11-01)

Macrolide antibiotics activate the integrated stress response and promote tumor proliferation
Yazar:: Xin Yu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Macrolide antibiotics and their place in therapy of upper respiratory tract infections therapy
Yazar:: A. Y. Ovchinnikov, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineage.
Yazar:: Carolina Aquilino, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Place of Semisynthetic Penicillins and Macrolides in Antibiotic Therapy for Respiratory Infections in Children
Yazar:: A.Ye. Abaturov, ve diğerleri
Baskı/Yayın Bilgisi: (2014-09-01)

What’s the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed
Yazar:: Katy J. L. Bell, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Antibiotics for sore throat
Yazar:: Mar, D, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients
Yazar:: Mengyuan He, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Adverse events in British hospitals. Retrospective case record analysis has been superseded.
Yazar:: Ferner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
Yazar:: Hisanori Domon, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro
Yazar:: Toshikazu Shimane, ve diğerleri
Baskı/Yayın Bilgisi: (2001-01-01)

Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice
Yazar:: Hajime Terao, ve diğerleri
Baskı/Yayın Bilgisi: (2003-01-01)

Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens
Yazar:: Deepjyoti Paul, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Stress Degradation Studies of Macrolide Antibiotics “Roxithromycin, Tilmicosin and Tylosin” by Using HPLC
Yazar:: Bediha Akmese
Baskı/Yayın Bilgisi: (2020-03-01)